Today: 12 May 2026
Soluna Holdings Stock in Focus After SEC Clears Share Resale Plan
11 May 2026
2 mins read

Soluna Holdings Stock in Focus After SEC Clears Share Resale Plan

ALBANY, New York, May 11, 2026, 07:03 (EDT)

Soluna Holdings Inc (NASDAQ: SLNH) got the green light from the U.S. Securities and Exchange Commission on its resale registration statement, clearing the way for 2,459,400 common shares tied to recent financing moves. The renewable data center firm picked up SEC effectiveness for its Form S-3 at 5:00 p.m. on May 8, following an active April.

The filing’s key point: selling stockholders, not Soluna, get the green light to resell shares related to previous private placements. Soluna spelled out in the prospectus that it won’t see any proceeds from these sales. That leaves the spotlight on dilution risk and the company’s ongoing push to secure funding for bitcoin hosting and AI-ready infrastructure.

Soluna has wrapped up its $53 million purchase of the Briscoe Wind Farm and now holds 100% of Project Dorothy 1A. The company also kicked off a 3-megawatt bitcoin mining project with Sazmining and pushed Blockware hosting capacity past the 17 MW mark. Nasdaq listing compliance has been restored as well, following SEC clearance.

The prospectus lists 2.4 million registered shares tied to a warrant issued to YA II PN Ltd on April 15, along with 59,400 shares issued or to be issued to Harmattan Energy Ltd from a previous merger agreement. Selling stockholders have the option to offload these shares through an exchange, private transactions, or negotiated deals. Still, the registration alone doesn’t compel them to sell.

Soluna’s expansion financing is detailed in the same prospectus. The company put down $6 million at closing to acquire the rest of Project Dorothy 1A and still faces a $10.5 million payment due by July 1. On top of that, a securities purchase agreement with YA gave Soluna access to as much as $12 million in unsecured loans.

Soluna aims to convert surplus renewable energy into computing power. In April, the company reported its hosted hash rate climbed to an average 4,629 petahashes per second, up from 4,439 in March. Proprietary bitcoin mined, however, edged down to 8.8 BTC from 9.7 BTC.

Not all of the project news was upbeat, but things stayed largely on track operationally. Soluna reported that both Project Dorothy 2 and Project Sophie hit full customer capacity in April. Over at Project Kati 1, the 35 MW K1B phase wrapped up mechanical work and moved into the power commissioning stage. As for Project Kati 2, the company kicked off design work for the more than 300 MW site focused on AI and high-performance computing.

Last month, Chief Executive John Belizaire pointed to the Sazmining deal as evidence Soluna can turn “stranded renewable energy into high-performance computing.” Sazmining CEO and co-founder Kent Halliburton said the agreement targets “maximizing the value of a carbon-free energy asset.” Soluna

The regular Nasdaq session wasn’t open yet at publication time—official hours are 9:30 a.m. to 4:00 p.m. Eastern, per Nasdaq. Soluna reported on May 1 that its minimum-bid-price issue was resolved after the stock’s closing bid stayed at or above $1 between April 14 and April 29.

Competition is thick. Soluna’s annual report points to Applied Digital and CoreWeave as key players in high-performance computing, listing Hut 8 on the bitcoin hosting side. The company notes that some competitors come to the table with deeper pockets, bigger brands, and greater scale.

Still, with the new resale clearance, the balance sheet remains under scrutiny. Soluna’s filings flag a string of risks—financing and debt, electricity prices, build timelines, demand for bitcoin, and competitors. Slippage on any of those fronts could hamper the very expansion that this recent string of deals is supposed to drive.

Stock Market Today

  • QuantumScape Shares Rise 11.7% on Eagle Line Launch and Initial Billings
    May 12, 2026, 5:46 PM EDT. QuantumScape (QS) gained 11.7% following the launch of its Eagle Line pilot-scale solid-state battery cell facility and initial $11 million in customer billings from ecosystem partners. The company reported a narrower GAAP net loss in Q1 2026, driven by reduced operating expenses. This marks a shift toward early commercialization and a potential licensing and royalty revenue stream, altering QuantumScape's risk profile and business model. Investors remain cautious as success depends on partner uptake and scaling production. Analysts' revenue forecasts vary widely, reflecting uncertainty around the new manufacturing blueprint. QuantumScape projects $544.5 million revenue and $33.3 million earnings by 2029, but some estimates are much lower, highlighting diverging market views.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
WhiteFiber’s Q1 Earnings Are Coming — Why the NC-1 AI Data Center Ramp Is the Stock’s Next Test
Previous Story

WhiteFiber’s Q1 Earnings Are Coming — Why the NC-1 AI Data Center Ramp Is the Stock’s Next Test

Helport AI Stock Jumps Nearly 50% Premarket as HPAI Draws Fresh Trader Interest
Next Story

Helport AI Stock Jumps Nearly 50% Premarket as HPAI Draws Fresh Trader Interest

Go toTop